DUBLIN--(BUSINESS WIRE)--Neuromod Devices Limited (“Neuromod”), the Irish medical device company specialising in the treatment of tinnitus, a chronic condition that affects 10-15% of the global ...

DUBLIN, Feb. 21, 2022 /PRNewswire/ -- Irish medical device company, Neuromod Devices Ltd. (Neuromod), has welcomed the findings of an independent study performed at the German Hearing Center (DHZ) at ...

Clinical trial concludes that bimodal neuromodulation combining sound and electrical stimulation of the tongue can significantly reduce tinnitus symptoms, and therapeutic effects can be sustained for ...

DUBLIN, April 29, 2024 /PRNewswire/ -- Lenire, the first and only FDA approved bimodal neuromodulation device for the treatment of tinnitus, has been included in the seminal "Textbook of Tinnitus," ...

An independent study from Germany confirms that bimodal neuromodulation can significantly reduce tinnitus symptoms in a real-world clinical setting. Irish medical device company, Neuromod Devices Ltd.

91.5% of patients experienced clinically meaningful reductions in tinnitus after 12 weeks of treatment with Lenire. 220 patients were analyzed, making the paper one of the largest real-world analyses ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted de novo approval to Neuromod Devices’ Lenire, a noninvasive device for the treatment of ...

Neuromod, a medical device company out of Dublin focused on treating tinnitus, secured €10 million ($10.9 million) in equity financing, expanding its Series B raise. The raise builds on the company's ...

A new clinical trial is to test whether a pocket-sized device that uses sound simulation to reboot faulty 'wiring' in the brain could cure people with the debilitating hearing disorder tinnitus. The ...

Dr. Sara K. Down, an audiologist and co-founder of the Duluth-based Hearing Wellness Center and Tinnitus Treatment Center, is receiving national recognition for the innovative integrated treatment ...